Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Cancer Lett. 2011 Oct 10;316(1):11–22. doi: 10.1016/j.canlet.2011.10.006

Fig. 3.

Fig. 3

IC50 of CTS in different prostate cancer cells. We determined the cell half-inhibition (IC50) of CTS in LNCaP, CWR22rv1, and PC3. Cells were seeded on 24 well plates in medium with 10%FBS for 24 hr. Medium was then refreshed to medium with 10 %CS-FBS for another 24 hr, and cells were treated with serial concentrations of CTS with or without 1 nM DHT for 2 days. Cells growth and IC50 value were determined by MTT assay. Half-inhibition of CTS was shown in Fig. 3A–3C when cells were treated with 10 nM DHT, and in Fig. 3D–3F when cells were not treated with DHT. Data represent mean ± SD of two independent experiments with three replicates in each experiment.